October 01, 2024

Evonik Oxeno expands production capacities for ELATUR® plasticizers

Evonik Oxeno is significantly expanding its production capacities for the INA-based plasticizers, ELATUR® CH (DINCH) and ELATUR® DINCD.

Significant capacity expansion planned for ELATUR® CH and ELATUR® DINCD to meet growing demand
Ensuring a reliable and secure supply of isononanol (INA)-based plasticizers for the European market
Ongoing commitment to scientific excellence with strict evaluation of VESTINOL® 9

Marl, Germany. Evonik Oxeno is significantly expanding its production capacities for the INA-based plasticizers, ELATUR® CH (DINCH) and ELATUR® DINCD. These products, introduced in recent years, have both now established themselves as new standard plasticizers with Evonik Oxeno customers.

“The capacity expansion marks another important milestone in the diversification of our plasticizer portfolio,” said the managing director of Evonik Oxeno, Frank Beißmann. “To meet the growing demand for these products, we will begin work this year.”

The capacity expansions will be integrated into the existing network of C4 plants in Marl. “With the expanded capacity, we can ensure our customers a high level of delivery reliability and quality from European production,” said Roland Pietz, Vice President of Oxo Alcohols & Plasticizers at Evonik Oxeno.

In addition to the ELATUR® product line, VESTINOL® 9 (DINP) remains a crucial component of Evonik’s Oxeno portfolio. Evonik Oxeno is dedicated to the strict scientific evaluation of this and all other plasticizers, ensuring a high level of supply security for its customers.

Like all Evonik Oxeno products, ELATUR® CH and ELATUR® DINCD can also be produced and supplied using mass-balanced methods from biobased, biocircular, circular raw materials, or utilizing green energy.

For more information, please visit the website c4-chemicals.evonik.com.

About Evonik

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.

About Performance Materials

The forever young classics of the Performance Materials Division stand for products and technologies that are continuously improved. They are the basis for many modern applications, for example in the areas of mobility, nutrition, pharmaceuticals or plastics. The divisions portfolio generated sales of €2.55 billion in 2023 with more than 1,700 employees.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.